Truist Financial Cuts Edwards Lifesciences (NYSE:EW) Price Target to $95.00

Edwards Lifesciences (NYSE:EW – Get Rating) had its price target trimmed by Truist Financial from $112.00 to $95.00 in a report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the medical research company’s stock. A number of other equities analysts have also recently commented on the company. Barclays assumed […]

Related Keywords

Mizuho ,Hokkaido ,Japan ,United States ,Bernardj Zovighian ,Michaela Mussallem ,Edwards Lifesciences ,Vanguard Group Inc ,Capital International Investors ,Edwards Lifesciences Corporation ,Canaccord Genuity Group ,Barclays ,Citigroup ,Fisher Asset Management ,Get Rating ,Truist Financial ,Marketbeat Ratings ,Moderate Buy ,Nova Scotia ,International Investors ,Asset Management ,Lifesciences Corporation ,Edwards Lifesciences Daily ,Nyse Ew ,Few ,Medical ,28176e10 ,Lower Price Target ,Truist Financial Co ,